| Product Code: ETC7375204 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Grenada`s import shipments of monoclonal antibodies in 2024 show a diverse mix of top exporting countries, including Saint Lucia, Barbados, Ireland, USA, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) indicates a shift from high to moderate concentration in 2024, reflecting a more balanced market. Despite a negative compound annual growth rate (CAGR) of -3.58% from 2020 to 2024, there was a positive growth rate of 3.24% from 2023 to 2024, suggesting a potential turnaround in the market for monoclonal antibodies in Grenada.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Monoclonal Antibody Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Monoclonal Antibody Market - Industry Life Cycle |
3.4 Grenada Monoclonal Antibody Market - Porter's Five Forces |
3.5 Grenada Monoclonal Antibody Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Grenada Monoclonal Antibody Market Revenues & Volume Share, By Production, 2021 & 2031F |
3.7 Grenada Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Grenada Monoclonal Antibody Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Grenada Monoclonal Antibody Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Monoclonal Antibody Market Trends |
6 Grenada Monoclonal Antibody Market, By Types |
6.1 Grenada Monoclonal Antibody Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Grenada Monoclonal Antibody Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 Grenada Monoclonal Antibody Market Revenues & Volume, By Murine, 2021- 2031F |
6.1.4 Grenada Monoclonal Antibody Market Revenues & Volume, By Chimeric, 2021- 2031F |
6.1.5 Grenada Monoclonal Antibody Market Revenues & Volume, By Humanized, 2021- 2031F |
6.1.6 Grenada Monoclonal Antibody Market Revenues & Volume, By Human, 2021- 2031F |
6.2 Grenada Monoclonal Antibody Market, By Production |
6.2.1 Overview and Analysis |
6.2.2 Grenada Monoclonal Antibody Market Revenues & Volume, By In Vivo, 2021- 2031F |
6.2.3 Grenada Monoclonal Antibody Market Revenues & Volume, By In Vitro, 2021- 2031F |
6.3 Grenada Monoclonal Antibody Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Grenada Monoclonal Antibody Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 Grenada Monoclonal Antibody Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.4 Grenada Monoclonal Antibody Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.3.5 Grenada Monoclonal Antibody Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 Grenada Monoclonal Antibody Market Revenues & Volume, By Microbial Diseases, 2021- 2031F |
6.3.7 Grenada Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Grenada Monoclonal Antibody Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 Grenada Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Grenada Monoclonal Antibody Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.4 Grenada Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Monoclonal Antibody Market Import-Export Trade Statistics |
7.1 Grenada Monoclonal Antibody Market Export to Major Countries |
7.2 Grenada Monoclonal Antibody Market Imports from Major Countries |
8 Grenada Monoclonal Antibody Market Key Performance Indicators |
9 Grenada Monoclonal Antibody Market - Opportunity Assessment |
9.1 Grenada Monoclonal Antibody Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Grenada Monoclonal Antibody Market Opportunity Assessment, By Production, 2021 & 2031F |
9.3 Grenada Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Grenada Monoclonal Antibody Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Grenada Monoclonal Antibody Market - Competitive Landscape |
10.1 Grenada Monoclonal Antibody Market Revenue Share, By Companies, 2024 |
10.2 Grenada Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here